SAN FRANCISCO, October 17, 2018 /PRNewswire/ --
The global crohn's disease therapeutics
market size is expected to reach USD 4.7 billion by 2025, according to a new
report by Grand View Research, Inc., registering a 2.4% CAGR during
the forecast period. Increasing awareness of the disease, coupled
with rising initiatives by regulatory bodies for development of
novel treatment options, is estimated to provide the market with
high growth potential.
(Logo:
https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg
)
For instance, the American Gastroenterological Association
(AGA), in collaboration with Pfizer, supports research projects
related to inflammatory bowel diseases and has offered three grants
in their name. The Crohn's & Colitis Foundation, European
Federation of Crohn's & Ulcerative Colitis Associations, and
American Autoimmune Related Diseases Association are some of the
organizations providing funds for research.
Furthermore, increase in prevalence of Crohn's disease has
directed many companies to collaborate with various regulatory
bodies and research institutes to introduce novel and effective
treatment for the condition. In 2016, Pfizer's Centers for
Therapeutic Innovation (CTI) collaborated with Johns Hopkins University to discover new medicines
to treat Crohn's disease and ulcerative colitis.
Browse full research report with TOC on
"Crohn's Disease Therapeutics Market Size,
Share & Trends Analysis Report By Therapy Type
(Anti-inflammatory, Immune System Suppressors, Antibiotics,
Surgical), By Region, And Segment Forecasts, 2018 -
2025" at:
http://www.grandviewresearch.com/industry-analysis/crohns-disease-therapeutics-market
Further Key Findings From the Report Suggest:
- The global Crohn's disease therapeutics market size was
estimated at USD 3.8 billion in 2016
and is expected to register a CAGR of 2.4% from 2017 to 2025
- Anti-inflammatory emerged as the largest therapy type segment
in 2016 due to its efficacy, while immune system suppressors
emerged as the fastest growing segment owing to reduction in
surgeries and hospitalization rates
- North America dominated in
terms of revenue in 2016 owing to rise in prevalence of the disease
and increase in involvement of regulatory bodies in terms of
funding R&D initiatives
- Asia Pacific is anticipated to
witness lucrative growth at a CAGR of over 4.0% over the forecast
period due to various developments in healthcare infrastructure and
rapid economic development across major emerging economies such as
India and China
- Some of the key players in the market are Johnson & Johnson
Services Inc.; Pfizer Inc.; Allergan; and AbbVie Inc.
Browse related reports by Grand View Research:
- Orthopedic Bone Cement Market - The global
orthopedic bone cement market size was estimated at USD 692.8 million in 2016.
- Healthcare Satellite Connectivity Market - The
global healthcare satellite connectivity market size was valued at
USD 5.1 billion in 2016 and is
projected to grow with CAGR of 7.1% during the forecast
period.
- Non-PVC IV Bags Market - The global non-PVC IV
bags market size was estimated at USD 1.11
billion in 2016.
- Histology and Cytology Market - The global
histology & cytology market size was estimated at USD 8.6 billion in 2016.
Grand View Research has segmented the global
Crohn's disease therapeutics market on the basis of
therapy type and region:
- Crohn's Disease Therapeutics Type Outlook
(Revenue, USD Million, 2014 - 2025)
- Non-Surgical
- Anti-Inflammatory
- Immune system suppressors
- Antibiotics
- Others
- Surgical
- Crohn's Disease Therapeutics Regional Outlook
(Volume, Tons; Revenue, USD Million, 2014 - 2025)
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Explore the BI enabled intuitive market research
database, Grand View Compass, by Grand View Research,
Inc.
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company
provides syndicated research reports, customized research reports,
and consulting services. To help clients make informed business
decisions, we offer market intelligence studies ensuring relevant
and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com
SOURCE Grand View Research, Inc.